NCT05518006

Brief Summary

An investigation of the dietary supplement marketed as "Premama Balance" on markers of subjective wellbeing in trial participants such as common symptoms of PMS and menstrual symptoms, as well as its effects on aiding in returning to their perceived regular/normal menstrual cycle.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 26, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

December 30, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

6 months

First QC Date

August 24, 2022

Last Update Submit

April 1, 2024

Conditions

Keywords

PMSMenstrual DiscomfortHormone DisturbanceMenstrual PainMenstrual Irregularity

Outcome Measures

Primary Outcomes (2)

  • Return to perceived regular/normal menstrual cycle

    Survey Based Assessment of changes in menstrual cycle

    6 Months

  • Changes in PMS and Menstrual Symptoms: Cramps, Bloating, Mood swings

    Survey-based assessment of changes in PMS and Menstrual symptoms

    6 Months

Study Arms (2)

PreMama Balance

EXPERIMENTAL

Each day, the participants will take 1 packet of Premama Balance, dissolved in one glass (8oz+) of water. Premama Balance may be taken with or without food. Should participants present themselves with a sensitive stomach, it is recommended to take the drink with or after a meal to avoid an upset stomach. Participants will repeat this process daily for 6 months/24 weeks (study period) until the study is complete. At week 12 and in week 24, the participants will take a survey and a hormone test to track progress. In total there will be 3 surveys and 3 hormone tests. Additionally, participants will fill out a weekly consumption survey to track compliance.

Dietary Supplement: PreMama Balance

Placebo Drink

PLACEBO COMPARATOR

Each day, the participants will take 1 packet of Placebo Drink, dissolved in one glass (8oz+) of water. Placebo Drink may be taken with or without food. Should participants present themselves with a sensitive stomach, it is recommended to take the drink with or after a meal to avoid an upset stomach. Participants will repeat this process daily for 6 months/24 weeks (study period) until the study is complete. At week 12 and in week 24, the participants will take a survey and a hormone test to track progress. In total there will be 3 surveys and 3 hormone tests. Additionally, participants will fill out a weekly consumption survey to track compliance.

Dietary Supplement: Placebo Drink

Interventions

PreMama BalanceDIETARY_SUPPLEMENT

Premama Balance is a blend of the following: Vitex (Chasteberry Extract), commonly used to help regulate hormones; Antioxidants, Selenium, and Magnesium, also help support the cleansing of hormonal birth control from the liver and help strengthen the uterine lining.

PreMama Balance
Placebo DrinkDIETARY_SUPPLEMENT

Blended Placebo drink

Placebo Drink

Eligibility Criteria

Age20 Years - 42 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Must be in good health (don't report any medical conditions asked in the screening questionnaire)
  • Must be on hormonal birth control (containing both progesterone and estrogen) for the past 6 months \& willing to stop using it to participate in the study
  • Must be willing to get off of hormonal birth control for the study period
  • Must be able to track their menstrual cycle
  • BMI under 40
  • Agree to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study
  • Willingness to adhere to the dietary supplement regimen
  • Willingness to refrain from any other dietary supplements targeting the menstrual cycle and hormone control during the study period
  • Is able to communicate in English
  • Is willing and able to share feedback via the used technology portal
  • Must provide written informed consent (ICF)

You may not qualify if:

  • History of oncological (including ovarian cancer) or psychiatric conditions
  • History of uncontrolled health conditions
  • History of hysterectomy or ovariectomy
  • History of diabetes \& thyroid disorders
  • Smoker
  • More than 3 servings of alcohol a day
  • Undergoing hormonal therapy of any kind
  • Menopausal or peri-menopausal
  • Not starting any other form of contraceptive other than condoms, abstinence, planned sexual intercourse
  • Usage of any medication or herbal remedies/supplements which can affect the menstrual cycle or hormonal balance
  • If currently taking allowed supplements, the dosage needs to remain the same throughout the entirety of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Endocrine System DiseasesDysmenorrheaMenstruation Disturbances

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Susanne Mitschke

    Citruslabs

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2022

First Posted

August 26, 2022

Study Start

December 30, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

April 3, 2024

Record last verified: 2024-04